Thousand Oaks Biopharmaceuticals nets $45 million in funding round

You are here: Home > Latest news > Current Article

Thousand Oaks Biopharmaceuticals nets $45 million in funding round

By Staff Report / Thursday, January 3rd, 2019 / Comments Off on Thousand Oaks Biopharmaceuticals nets $45 million in funding round

Chinese-owned biotech Thousand Oaks Biopharmaceuticals announced that it had netted $45 million in a Series A funding round, led by New Alliance Capital, Addor Capital, and Tenyall & Sumin. With the funds, the company said it plans to build a large-scale cell culture media manufacturing facility outside Shanghai. “This round of financing allows us to…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.